Stocks

About Us

Home

Stocks

Suven Pharmaceuticals Ltd.

The current prices were last updated on 17 Jan.

Join waitlist

Suven Pharmaceuticals Ltd.

₹1,079.45

+404.65 (59.97%)

Sector:

Healthcare

Industry:

Pharmaceuticals & Drugs

Healthcare

Pharmaceuticals & Drugs

NSE

BSE

The current prices were last updated on 17 Jan

Price

1.02%

3.20%

-13.99%

-13.71%

26.16%

59.97%

100.27%

572.55%

Max

572.55%

3.20%

-13.99%

59.97%

100.27%

572.55%

Max

572.55%

Overview

Financials

Ratios

Shareholdings

FAQs

Suven Pharma Overview

1,065.10

Today's Low

1,090.15

Today's High

1,065.10

Open

1,070.40

Prev. Close

585.20

52W Low

1,360.00

52W High

P/E

57.36

Sector P/E

30.83

P/B

8.41

Sector P/B

3.10

Adj EPS

11.80

BVPS

80.48

OPM(%)

38.60

NPM(%)

28.56

ROE(%)

15.87

ROCE(%)

21.22

D/E

0.02

Div. Yld(%)

Suven Pharma Historical Returns

1 Week

3.20 %

1 Month

-13.99 %

3 Month

-13.71 %

6 Month

26.16 %

1 Year

59.97 %

3 Year

100.27 %

5 Year

572.55 %

Max

572.55 %

Suven Pharma Financials

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

*All values are in Rs. Cr

Consolidated

Name	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Net Sales	257.72	230.69	252.93	219.82
Sales	257.72	230.69	252.93	219.82
Less: Excise Duty	0	0	0	0
Operating Expenses	153.71	150.76	179.59	154.68
Raw Material Cost	47.08	38.30	71.43	63.53
Power cost	0	0	0	0
Employee Cost	51.87	45.62	39.39	32.83
Other Expenses	54.76	66.84	68.77	58.32
Increase / Decrease In Stocks	4.98	25.30	12.30	8.91
Purchase of Finished Goods	0	0	0	0
Manufacturing Expenses	49.78	41.54	56.48	49.40
General Administration Expenses	0	0	0	0
Selling & Distribution Expenses	0	0	0	0
Misc Expenses	0	0	0	0
Loss Foreign Exchange	0	0	0	0
Loss Foreign Exchange Loan	0	0	0	0
Expenses Capitalised	0	0	0	0
Operating Profit (Excluding OI)	104.01	79.93	73.34	65.15
Other Income	14.12	18.16	17.05	14.35
Other Income Normal	14.12	18.16	17.05	14.35
Exceptional Items	0	0	0	0
Operating Profit Margin	40.36	34.65	29.00	29.64
EBIDTA	118.13	98.09	90.40	79.49
Less: Interest	1.67	1.60	2.30	1.27
Less: Depreciation	16.96	13.40	17.25	12.75
Profit Before Tax	99.50	83.09	70.85	65.47
Less: Tax	17.52	22.32	17.48	18.72
Net Profit	81.98	60.77	53.37	46.75
Earnings Per Share	3.23	2.39	2.10	1.84
Net Profit Margin	31.81	26.34	21.10	21.27

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Net Sales	1,051.35	1,340.33	1,320.22	1,009.72
Sales	1,051.36	1,341.49	1,321.12	1,009.72
Less: Excise Duty	-	-	-	-
Operating Expenses	645.54	766.17	738.50	566.72
Raw Material Cost	262.23	423.91	454.40	305.93
Power cost	48.30	73.93	59.55	44.20
Employee Cost	135.92	118.25	100.48	76.23
Other Expenses	149.94	171.02	184.41	148.73
Other Manufacturing Expenses	89.05	109.62	129.24	105.31
Selling and administrative expenses	35.90	33.87	28.99	27.73
Selling Expenses	10.35	17.64	19.80	10.53
Miscellaneous Expenses	14.63	9.90	6.37	5.16
Less: Expenses Capitalised	-	-	-	-
Operating Profit (Excluding OI)	405.81	574.16	581.72	443.00
Other Income	61.91	46.36	92.38	14.24
Other Income Normal	61.91	46.36	92.38	14.24
Exceptional Items	-	-	-	-
Operating Profit Margin	38.60	42.84	44.06	43.87
EBIDTA	467.72	620.53	674.10	457.24
Interest	7.45	12.81	8.53	11.67
Depreciation	54.60	47.99	39.10	31.64
Profit Before Tax	405.67	559.73	667.59	467.67
Tax	105.39	148.44	213.78	105.33
Net Profit	300.28	411.29	453.80	362.34
Equity Dividend %	-	600.00	500.00	200.00
Earnings Per Share	11.80	16.16	17.83	14.23
Net Profit Margin	28.56	30.66	34.35	35.89

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity And Liabilities	2,353.25	2,110.07	1,966.81	1,576.22
Shareholder's Funds	2,050.66	1,735.18	1,527.18	1,180.81
Share Capital	25.46	25.46	25.46	25.46
Share Warrants & Outstandings	1.99	0	0	0
Total Reserves	2,023.21	1,709.73	1,501.72	1,155.35
Reserve excluding Revaluation Reserve	2,023.21	1,709.73	1,501.72	1,155.35
Revaluation reserve	-	-	-	0
Non-Current Liabilities	96.53	71.79	92.11	73.91
Secured Loans	-	4.56	28.44	35.59
Unsecured Loans	-	-	-	-
Deferred Tax Assets / Liabilities	64.79	58.23	54.32	30.93
Other Long Term Liabilities	31.74	8.99	9.36	7.39
Rest of the Other Long Term Liabilities	21.24	0.70	0.46	0.74
Long Term Trade Payables	-	-	-	-
Long Term Provisions	10.50	8.30	8.89	6.65
Current Liabilities	206.06	303.09	347.52	321.51
Trade Payables	42.36	70.09	105.90	82.93
Other Current Liabilities	21.22	19.84	29.54	28.57
Short Term Borrowings	38.58	64.60	67.13	105.64
Short Term Provisions	103.90	148.56	144.94	104.36
Assets	2,353.25	2,110.07	1,966.81	1,576.22
Non-Current Assets	990.90	954.70	701.66	909.68
Net Block	669.62	663.33	534.19	441.16
Gross Block	927.38	875.60	693.81	569.62
Less: Accumulated Depreciation	257.76	212.27	159.62	128.46
Less: Impairment of Assets	-	-	-	-
Lease Adjustment	-	-	-	-
Capital Work in Progress	178.97	165.09	29.99	96.15
Other Non Current Assets	142.20	126.28	137.47	372.20
Long Term Investments	130.58	117.10	117.10	361.19
Long Term Loans & Advances	11.41	9.19	13.07	10.85
Other Non Current Assets	0.20	-	7.30	0.16
Current Assets	1,362.35	1,155.37	1,265.16	666.54
Inventories	231.20	312.81	283.42	201.08
Account Receivables	133.66	110.94	236.37	102.38
Cash and Bank	50.50	68.01	47.31	9.65
Other Current Assets	946.99	663.60	698.06	353.43
Current Investments	773.90	418.94	481.22	180.59
Other Current Assets	11.90	11.46	10.87	11.83
Short Term Loans and Advances	161.19	233.21	205.97	161.00
Book Value	80.48	68.16	59.99	46.39

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activity	358.48	457.20	330.00	382.55
Profit Before Tax	405.67	559.73	667.59	467.67
Adjustments	15.35	37.46	40.63	36.48
OCF Before Working Capital	421.02	597.19	708.22	504.16
Working Capital Changes	47.41	5.77	-193.97	-12.17
Taxes Paid	-109.95	-145.76	-184.26	-109.44
Cash from Investing Activity	-362.25	-195.01	-136.14	-311.40
Net Fixed Assets Purchased	-	-	-	-
Fixed Assets Purchased	-	-	-	-
Fixed Assets Sold	-	-	-	-
Investment Purchased	405.67	559.73	667.59	467.67
Investment Sold	-	-	-	-
Dividends Recieved	-	-	-	-
Interest Recieved	-	-	-	-
Subsidiary Investments	-	-	-	-
Cash from Financing Activity	-13.80	-241.95	-156.48	-75.66
Proceeds From Shares	-	-	-	-
Net Long Term Borrowings	-	-	-	-
Proceeds From Borrowings	-	-	-	-
Repayment From Borrowings	-	-	-	-
Interest Paid	-	-	-	-
Dividend Paid	-	-	-	-
Net Cash Flow	-17.57	20.24	37.38	-4.51
Opening Cash & Cash Equivalents	64.80	44.56	7.18	11.70
Effect of FX	0	-	0	0
Closing Cash & Cash Equivalents	-	-	-	-
Free Cash Flow (est)	-	-	-	-
Net Capex (est)	-	-	-	-

*All values are in Rs. Cr

Suven Pharma Financial Ratios

Valuations

Profitability

Efficiency

Leverage

Operational

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Book Value Per Share	80.48	68.16	59.99	46.39	66.37
P/B	8.41	6.93	10.30	10.68	3.04
P/E	57.36	29.26	34.66	34.80	4.04
EV/EBIDTA	36.80	19.39	23.41	27.87	6.79
Market Cap/Sales	16.38	8.98	11.92	12.49	3.08

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Net Profit Margin (%)	28.56	30.66	34.35	35.89	38.02
Gross Margin (%)	38.60	42.80	44.03	43.87	46.15
Operating Profit Margin (%)	38.60	42.84	44.06	43.87	46.15

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
ROE (%)	15.87	25.21	33.52	35.78	44.58
ROCE (%)	21.22	33.41	45.92	40.76	50.21
ROA (%)	13.46	20.18	25.62	25.26	30.07
Capital Adequacy Ratio (%)	-	-	-	-	-

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
D/E Ratio	0.02	0.04	0.06	0.12	0.22
Interest Coverage Ratio	55.44	44.69	79.29	41.09	18.54
Current Ratio	6.61	3.81	3.64	2.07	1.60

Name	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash Conversion Cycle (Days)	70.99	48.66	26.27	13.19	29.65
Days Receivables (Days)	42.46	47.25	46.80	39.69	57.94
Inventory Days (Days)	94.43	81.11	66.93	67.95	72.66
Days Payables (Days)	65.90	79.70	87.45	94.44	100.95
Free Cash Flow to Share	13.66	6.98	8.76	10.63	22.93
Inventory Turnover Ratio	3.87	4.50	5.45	5.37	5.02
Asset Turnover Ratio	0.47	0.66	0.75	0.70	0.79

Suven Pharma Shareholding Pattern

Summary

Promoter

FII

MF

Retail

Others

Suven Pharma Shareholding Breakup

Name	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Promoter	50.10%	50.10%	50.10%	60.00%
Indian Promoters	-	-	-	9.90
Foreign Promoters	50.10	50.10	50.10	50.10
FII	10.70%	9.80%	9.54%	10.14%
MF	14.12%	14.78%	15.26%	13.40%
Retail	9.76%	10.07%	10.51%	10.87%
Others	15.32%	15.25%	14.59%	5.59%

Suven Pharma FAQs

What is the current share price of Suven Pharma?

As of 17 Jan, the current share price of Suven Pharma is ₹1079.45 per share.

What is the P/E ratio of Suven Pharma?

The Price-to-Earnings (P/E) ratio of Suven Pharma is 57.36. It is calculated based on its most recent quarterly earnings. The P/E ratio compares the company's current share price to its quarterly earnings per share (EPS), helping investors evaluate its market value relative to its earnings.

What is the EPS for Suven Pharma?

As reported in the latest quarterly financial statements, the Earnings Per Share (EPS) for Suven Pharma is ₹11.80. EPS is calculated by dividing the company's net income for the quarter by the number of outstanding shares, indicating how much profit is allocated to each share of stock during that period.

What is the ROE and ROCE of Suven Pharma?

As per latest financial reports, Suven Pharma has a Return on Equity (ROE) of 15.87% and a Return on Capital Employed (ROCE) of 21.22%. ROE measures the profitability relative to shareholders' equity, while ROCE assesses how efficiently the company utilizes its capital to generate profits.

What is the debt-to-equity ratio of Suven Pharma?

The debt-to-equity ratio of Suven Pharma is 0.02 according to its latest financial report. This ratio compares the company's total liabilities to its shareholder equity and is used to evaluate its financial leverage and risk level.

Similar stocks

SUNPHARMA

1786.55

NSE

+29.70

(1.69%)

DIVISLAB

5916.05

NSE

+39.20

(0.67%)

CIPLA

1442.30

NSE

-4.90

(0.34%)

DRREDDY

1309.40

NSE

-27.80

(2.12%)

TORNTPHARM

3174.85

NSE

-40.20

(1.27%)

Excited to Invest?

Join our waitlist now and get early access to our platform!

Similar stocks

SUNPHARMA

1786.55

NSE

+29.70

(1.69%)

DIVISLAB

5916.05

NSE

+39.20

(0.67%)

CIPLA

1442.30

NSE

-4.90

(0.34%)

DRREDDY

1309.40

NSE

-27.80

(2.12%)

TORNTPHARM

3174.85

NSE

-40.20

(1.27%)

Excited to Invest?

Join our waitlist now and get early access to our platform!

TRADE CONFIDENTLY

Address - 2nd Floor HSR Layout, 17th cross road Bengaluru – 560103

+91-8197368610

Home

About us

All stocks

Partners

NIFTY Top 10

Reliance Industries Limited

Tata Consultancy Services Limited

HDFC Bank Limited

Bharti Airtel Limited

ICICI Bank Limited

Infosys Limited

State Bank of India

Hindustan Unilever Limited

Life Insurance Corporation Of India

ITC Limited

Connect with us

Mintcap Brokers Private Limited

SEBI Registration : INZ000322732 | BSE Membership No: 6903

NSE Membership No : 90430